|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 38/18 | (2006.01) | ||
| A61K 38/1816 | (2013.01) | ||
| A61K 38/19 | (2006.01) | ||
| A61K 39/39591 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 47/22 | (2013.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Number of the document | 3381445 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18167567.9 |
| Date of filing the European patent application | 2008-11-13 | |
| (97) | Date of publication of the European application | 2018-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 988354 P | 2007-11-15 | US |
| (72) |
SLOEY, Christopher, James , US
KO, Jason , US
LI, Tiansheng , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | AQUEOUS FORMULATION OF ANTIBODY STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION |
| AQUEOUS FORMULATION OF ANTIBODY STABLISED BY ANTIOXIDANTS FOR PARENTERAL ADMINISTRATION |